About 1 400 reports

  • CHRONIC PAIN
  • 3.2.2.1. CLASSIFICATION OF CHRONIC PAIN

CHRONIC PAIN AND MENTAL HEALTH ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##. ##.

  • Musculoskeletal Disorder
  • Pathology
  • North America
  • United States
  • Eli Lilly & Co.
  • Chronic Pain
  • Chronic Pain

The Medical Cannabis Market for Chronic Pain in North America perceived the value of USD ##. ## million in 2014 and USD Pain is the chief reason behind the employment of cannabis in medicines so as to provide relief to the patients suffering from various kind of

  • Musculoskeletal Disorder
  • Pathology
  • World
  • Market Size
  • Canopy Growth Corporation
  • Fighting Acute And Chronic Pain With Innovative Technology
  • Expansion Of Coverage For Podiatry Services

At least one in four older people are affected by chronic foot pain, influencing their mobility and quality of life. xxii Access to healthcare services and availability of skilled podiatrists will drive the market in the future.

  • Diabetes
  • Health Services
  • Hospital
  • Musculoskeletal Disorder
  • Pathology
  • Fighting Acute And Chronic Pain With Innovative Technology
  • Expansion Of Coverage For Podiatry Services

At least one in four older people are affected by chronic foot pain, influencing their mobility and quality of life. xxii Access to healthcare services and availability of skilled podiatrists will drive the market in the future.

  • Diabetes
  • Health Services
  • Hospital
  • Musculoskeletal Disorder
  • Pathology

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Pathology
  • France
  • United States
  • Market Shares
  • Market Size

Opioids are considered one of the most effective drug classes for the treatment of chronic pain.

  • Musculoskeletal Disorder
  • Pathology
  • North America
  • World
  • Market Size

Chronic Neuropathic Pain KOL Survey Biomedtracker performed a ##-question survey of ## United States neurologists who currently treat patients with chronic neuropathic pain and prescribe opioids to at least some of their patients with chronic neuropathic

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • United States
  • shows the etiology of chronic pain.
  • Typically chronic

Tsuda, M. et al. (2013) ' Microglia and intractable chronic pain', Glia, ##(##), pp. ##-##. doi: ##. ##/ glia. ##.

  • Musculoskeletal Disorder
  • Pathology
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • U.S. PAIN MANAGEMENT AND SURGICAL DEVICES MARKET REVENUE, BY APPLICATION (2018) ($MN), CAGR (%)
  • 10.9.4 KEY DEVELOPMENTS

ACCORDING TO PAIN ALLIANCE EUROPE, ONE OUT OF FIVE EUROPEANS ARE SUFFERING FROM CHRONIC PAIN AND IT CONSIDERED AS ONE OF THE MAIN CAUSES OF DISABILITY, WITH CONSIDERABLE NEGATIVE EFFECTS ON PRODUCTIVITY AT WORK.

  • Analgesic
  • Musculoskeletal Disorder
  • Pathology
  • Surgical Equipment
  • Therapy
  • 7.4 St. Jude Medical Inc.

Home Healthcare ##.

  • Pathology
  • World
  • Asahi Kasei Corporation
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • SCS DEVICES MARKET FOR CHRONIC PAIN IN CANADA, CONSERVATIVE,
  • SCS DEVICES MARKET FOR CHRONIC PAIN IN GERMANY,

EXAMPLE HIGHLIGHTS ##.

  • Mental Health
  • Pathology
  • World

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Pathology
  • France
  • Germany
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • Japan
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • United States
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • United Kingdom
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • Italy
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • Germany
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • France
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Pain
  • Pathology
  • Spain
  • Market Shares
  • Market Size
  • PRODUCT PROFILE - LYRICA
  • 4.1 OVERVIEW

Chronic Pain Syndromes.

  • Musculoskeletal Disorder
  • Pathology
  • Forecast
  • Daiichi Sankyo Company
  • Depomed, Inc.
  • 13.4.4 Product/Services Portfolio
  • 13.4 2MORROW INC. 13.4.1 Key Facts

The company engaged to provide services for smoking cessation, weight, stress/ anxiety and chronic pain and offer programs including SmartQuit, weight management program, stress (and anxiety) program and chronic pain program.

  • Musculoskeletal Disorder
  • Pathology
  • World
  • Forecast
  • Market Size

Healthcare providers recommend a urinalysis test in case of back pain, abdominal pain, painful urination and blood in the urine.

  • Autoimmune Disease
  • Diagnostics
  • Healthcare
  • Musculoskeletal Disorder
  • Pathology

Deep Brain Stimulation Device Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Mental Health
  • Pathology
  • APAC
  • World
  • Market Size

Brain Implants Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Mental Health
  • Pathology
  • APAC
  • World
  • Market Size
  • 5.1 CHRONIC PAIN NEUROMODULATION MARKET AND FORECAST
  • GLOBAL - FORECAST FOR CHRONIC PAIN NEUROMODULATION MARKET (MILLION US$), 2016 - 2021

The prevalence of chronic back pain is one of the key drivers of the SCS market.

  • Pathology
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • 12.1 BIBLIOGRAPHY

THE STUDY WAS CONDUCTED IN PEOPLE AGES ##-## YEARS WITH CHRONIC BACK PAIN, FROM ## US RHEUMATOLOGIST PRACTICES DURING 1985-2011.

  • Musculoskeletal Disorder
  • Pathology
  • United States
  • Forecast
  • Pfizer Inc.
  • Comparison by application
  • Global wearable pain management devices market - Year over year growth 2018-2022 (%)

As of 2015, approximately ##% of American adults have significant chronic pain or severe pain.

  • Musculoskeletal Disorder
  • Pathology
  • Fitbit, Inc.
  • Garmin Ltd.
  • Omron Corporation
  • 7.2 SURGICAL APPLICATIONS

ACCORDING TO THE NATIONAL CENTER FOR COMPLEMENTARY AND INTEGRATIVE HEALTH, CLOSE TO ##% OF ADULTS IN THE US EXPERIENCED CHRONIC PAIN AND ##% HAD HIGH-IMPACT CHRONIC PAIN IN 2016.

  • Musculoskeletal Disorder
  • Pathology
  • North America
  • United States
  • Medtronic, Inc.

Jude Medical' s strong positions in fast-growing areas such as atrial fibrillation, heart failure, structural heart and chronic pain will complement Abbott' s leading positions in coronary interventions and mitral valve disease.

  • Pathology
  • World
  • B. Braun Medical
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Neurostimulation devices are available for a wide number of applications such as chronic pain, epilepsy, sleep apnea and
  • Neurostimulation Devices

Cost of pharmaceutical treatment for chronic pain is very pain.

  • Pathology
  • World
  • Boston Scientific Corporation
  • Integra LifeSciences Holdings Corporation
  • Jude Medical, Inc.